Address: 378 Roan Crescent, Corporate Part North, Randjespark,South Africa
Tel: +27115429500
Web: http://www.lithahealthcare.co.za/company-structure/pharmaceuticals/litha-pharma/pharmafrica.html
Pharmafrica (Pty) Ltd has been in business since 1995. It became a full member of the Litha Group in 2010 but has been in a partnership with Litha since 2006.
The company markets ethical and complimentary healthcare products to niche markets through a wholesaler and direct distribution network. Pharmafrica has a solid reputation and strong relationships within the hospital and specialist environment and are an approved GMP manufacturer.
Pharmafrica is also a member of SMASA (Self Medication Manufacturers Association of South Africa)
Key markets:
Hospitals – Private and Public
Selected Medical Specialists and GP’s
Clinics – Private and Public
Academic Institutions
Retail Pharmacy
Pharmafrica has representatives in all the major areas of South Africa and primarily target the following specialities:
Cardiology
Dermatology
Plastic Surgery
Ophthalmology
Urology
General Medical Practice
Ethical medicines:
Analgesics
Anti-psychotics
Anti-depressants
Viscoelastic in eye surgery
Ophthalmic products
Anti-glaucoma therapy
Urinary incontinence
Topical anti-inflammatories
Complementary medicines:
Nutritive supplements
Vitamin supplements
Scar Management and stretch marks
Ageing and sun damaged skin preparations
Pharmafrica head office is located in Johannesburg and distributes from their warehouse nationally. They have a regional office in Cape Town and a total of 14 sales representatives. The company has regulatory, financial,/admin, marketing, distribution and sales resources and a total of 32 employees.
Pharmafrica represents the following companies:
Goldshield Pharmaceuticals – United Kingdom
Thornton & Ross LTD. – United Kingdom
Bio-technology General (B.T.G) – Israel
Apogepha Arzneimittel GMBH – Germany
Sankyo Pharma – Germany
Ursapharm – Germany
Products:
Cerumol – Ear Drops for ear care
Biolon Prime – Eye care
Biolone – Eye care
Ecotrin – Therapy for Cardiovascular Disease
Stelazine – Treatment of acute and chronic psychoses
Detrunorm – Therapy for an overactive bladder
Elmetacin – Topical NSAIDS
Dyazide – Treatment of fluid retention (edema) and high blood pressure (hypertension).
Diamox- Treatment for Glaucoma
Parnate – Antidepressant
Kamillosan – Baby care ointment
Oculet – Eye care
DS-24 – Nutritional supplement
Trimega – Omega Nutritional supplement
Dermastine Range – Skin and Scar Care
Flexeze Capsules and Gel – Therapy for Arthritis
The South African affiliate of Indian pharma firm Cipla will begin manufacturing and distribution of remdesivir, a Covid-19 drug, in South Africa this month. The company’s priority is ensuring access…
Below is a roundup of latest news from South Africa’s life sciences and healthcare industries, including a call to overhaul patent laws to allow better access to COVID-19 drugs, innovation…
Kelly du Plessis is CEO & Founder of Rare Diseases South Africa, a registered NPO born out of necessity when her oldest child was diagnosed with Pompe disease at 11…
Trailing behind South Africa’s pharmaceutical market in both value and growth, the nation’s medical device industry has long enjoyed minimal barriers to entry and easy market access. But, with imminent…
The traditional model of healthcare has generally been limited to treatment in health facilities. But, when it comes to effectively treating more private and deeply personal health conditions, especially in…
Eclectic demographics, rapid patient recruitment, and a burgeoning population with a gradient of disease profiles—these seem to be the fundamentals truly driving growth in South Africa’s clinical trial industry. However,…
While South Africa faces a distinct set of challenges in effectively managing its healthcare sector, the ecosystem for innovation, particularly in the world of biotechnology remains fruitful. Bioentrepreneur Nick Duneas…
Hersol prides itself on producing high-quality products and is today one of the leading Pharmaceutical Contract Manufacturing Companies (CMOs) within the South African Market. The managing director discusses the development…
Albert Denoon (AB) and Jeff Hampton (JH) illustrate how the Crossroads and Campbell Institutes, two non-profit organizations funded by Baroque Medical, are well positioned to address South Africa’s current gaps…
The general manager of Bard SA, Charl De Klerk, illustrates the company’s growth ambitions within South Africa and Sub-Saharan Africa, while also depicting how Bard has adapted its therapeutic portfolio…
The head of KPMG’s life science division in Africa, Joubert Krugel, discusses the current state of South Africa’s healthcare system, the imminent trends taking place, and how the business community…
Marius Fourie highlights implications of the recent merger between the company’s two subsidiaries and the unparalleled levels of value and service the consolidated organization will offer. He also illustrates the affiliate’s strategies…
See our Cookie Privacy Policy Here
